Yepbio

Manufacturing · South Korea · 11-50 Employees

View Company Info for Free

Overview

Headquarters

A #1503 Keumkang Penterium It Tower 282 ...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Yepbio

Yepbio is a biotech company focused on neurodegenerative diseases, specifically developing precision medicine approaches for Parkinson's disease. The company integrates disease-modifying therapeutics with blood-based early diagnostic biomarkers and diagnostic kits, aiming to enhance clinical success and commercial value. Their lead product, YPD-01, is the world's first oral small-molecule therapy targeting the PARIS protein, which is linked to the progression of Parkinson's disease. Yepbio's innovative strategies are grounded in extensive research and aim to improve patient outcomes through biomarker-driven patient selection.Explore more
Popular SearchesYepbioSIC Code 28,283NAICS Code 32,325Show more

Yepbio Org Chart

PhoneEmail
HC
South Korea flag for contact location.

Managing Director

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Yepbio your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Frequently Asked Questions Regarding Yepbio

What is Yepbio's official website?
Yepbio's official website is www.yepbio.com
What is Yepbio's Revenue?
Yepbio's revenue is <$5 Million
What is Yepbio's SIC code?
Yepbio's SIC: 28,283
What is Yepbio's NAICS code?
Yepbio's NAICS: 32,325
How many employees does Yepbio have?
Yepbio has 11-50 employees
What industry does Yepbio belong to?
Yepbio is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What does Yepbio do?

Yepbio is a biotech company focused on neurodegenerative diseases, specifically developing precision medicine approaches for Parkinson's disease. The company integrates disease-modifying therapeutics with blood-based early diagnostic biomarkers and diagnostic kits, aiming to enhance clinical success and commercial value. Their lead product, YPD-01,... is the world's first oral small-molecule therapy targeting the PARIS protein, which is linked to the progression of Parkinson's disease. Yepbio's innovative strategies are grounded in extensive research and aim to improve patient outcomes through biomarker-driven patient selection.Read More

Is Yepbio a public company?
Yepbio is private company therefore does not currently have an official ticker symbol
See more information about Yepbio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.